1. Monoclonal Antibodies in Cancer Therapy: An Overview

   • Robert S. Kerbel

   ReviewPaper Pages: 409 - 410

2. Engineering Antibodies for the Clinic

   • Philipp Holliger
   • Heribert Bohlen

   OriginalPaper Pages: 411 - 419

3. Transgenic Mice as a Source of Fully Human Antibodies for the Treatment of Cancer

   • C. Geoffrey Davis
   • Michael L. Gallo
   • Jose R.F. Corvalan

   OriginalPaper Pages: 421 - 425

4. Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer

   • Harlan W. Waksal

   OriginalPaper Pages: 427 - 436

5. Target Antigens for Prostate Cancer Immunotherapy

   • Douglas C. Saffran
   • Robert E. Reiter
   • Owen N. Witte

   OriginalPaper Pages: 437 - 449

6. Monoclonal Antibody Therapy of Human Gliomas: Current Status and Future Approaches

   • Carol J. Wikstrand
   • Ilkcan Cokgor
   • Darell D. Bigner

   OriginalPaper Pages: 451 - 464

7. Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of Malignancy

   • Robert O. Dillman

   OriginalPaper Pages: 465 - 471

8. Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

   • Jean-Marc Schlaeppi
   • Jeanette M. Wood

   OriginalPaper Pages: 473 - 481

9. Prostate-specific Membrane Antigen (PSMA)-specific Monoclonal Antibodies in the Treatment of Prostate and Other Cancers

   • Michael C. Gong
   • Sam S. Chang
   • Warren D.W. Heston

   OriginalPaper Pages: 483 - 490

10. Volume Contents

    Volume Contents Pages: 491 - 493